Thrombospondin-1 expression in relation to p53 status and VEGF expression in human breast cancers
- 30 November 2004
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 40 (16) , 2417-2423
- https://doi.org/10.1016/j.ejca.2004.07.026
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Thrombospondin-1 Expression in Epithelial Ovarian Carcinoma: Association with p53 Status, Tumor Angiogenesis, and Survival in Platinum-Treated PatientsGynecologic Oncology, 2001
- Improving the Detection of p53 Mutations in Breast Cancer by Use of the FASAY, a Functional AssayThe Journal of Molecular Diagnostics, 2000
- The heparin binding 25 kDa fragment of thrombospondin‐1 promotes angiogenesis and modulates gelatinase and TIMP‐2 production in endothelial cellsThe FASEB Journal, 2000
- Heterogeneity of Endothelial Cells: The Specialized Phenotype of Human High Endothelial Venules Characterized by Suppression Subtractive HybridizationThe American Journal of Pathology, 1999
- Vascular endothelial growth factorEuropean Journal Of Cancer, 1996
- The p53 Gene in Breast Cancer: Prognostic Value of Complementary DNA Sequencing Versus ImmunohistochemistryJNCI Journal of the National Cancer Institute, 1996
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Thrombospondin in malignant and non-malignant breast tissueEuropean Journal of Cancer and Clinical Oncology, 1989
- Thrombospondin in Milk, Other Breast Secretions, and Breast TissueSeminars in Thrombosis and Hemostasis, 1987
- Immunohistochemical localisation of thrombospondin in human megakaryocytes and platelets.Journal of Clinical Pathology, 1983